PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VGR vs. VOR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


VGRVOR

Fundamentals


VGRVOR
Market Cap$2.36B$69.36M
EPS$1.26-$1.73
Total Revenue (TTM)$1.06B$12.23M
Gross Profit (TTM)$355.94M$9.49M
EBITDA (TTM)$260.21M-$86.75M

Correlation

-0.50.00.51.00.1

The correlation between VGR and VOR is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

VGR vs. VOR - Performance Comparison

The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
40.75%
-40.62%
VGR
VOR

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VGR vs. VOR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vector Group Ltd. (VGR) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VGR
Sharpe ratio
The chart of Sharpe ratio for VGR, currently valued at 1.71, compared to the broader market-4.00-2.000.002.004.001.71
Sortino ratio
The chart of Sortino ratio for VGR, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.006.002.61
Omega ratio
The chart of Omega ratio for VGR, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for VGR, currently valued at 1.84, compared to the broader market0.002.004.006.001.84
Martin ratio
The chart of Martin ratio for VGR, currently valued at 9.03, compared to the broader market0.0010.0020.0030.009.03
VOR
Sharpe ratio
The chart of Sharpe ratio for VOR, currently valued at -0.54, compared to the broader market-4.00-2.000.002.004.00-0.54
Sortino ratio
The chart of Sortino ratio for VOR, currently valued at -0.47, compared to the broader market-4.00-2.000.002.004.006.00-0.47
Omega ratio
The chart of Omega ratio for VOR, currently valued at 0.95, compared to the broader market0.501.001.502.000.95
Calmar ratio
The chart of Calmar ratio for VOR, currently valued at -0.46, compared to the broader market0.002.004.006.00-0.46
Martin ratio
The chart of Martin ratio for VOR, currently valued at -0.92, compared to the broader market0.0010.0020.0030.00-0.92

VGR vs. VOR - Sharpe Ratio Comparison


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.71
-0.54
VGR
VOR

Dividends

VGR vs. VOR - Dividend Comparison

Neither VGR nor VOR has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
VGR
Vector Group Ltd.
5.34%7.09%6.75%4.94%6.87%11.66%16.05%6.98%6.87%6.62%7.33%9.54%
VOR
Vor Biopharma Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

VGR vs. VOR - Drawdown Comparison


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-0.13%
-98.13%
VGR
VOR

Volatility

VGR vs. VOR - Volatility Comparison

The current volatility for Vector Group Ltd. (VGR) is 0.00%, while Vor Biopharma Inc. (VOR) has a volatility of 22.63%. This indicates that VGR experiences smaller price fluctuations and is considered to be less risky than VOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember0
22.63%
VGR
VOR

Financials

VGR vs. VOR - Financials Comparison

This section allows you to compare key financial metrics between Vector Group Ltd. and Vor Biopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items